✦ LIBER ✦

PND18 Cost- Effectiveness of Fingolimod on Patients With Multiple Sclerosis at the Public Mexican Health Care System

✍ Scribed by I.F. Soria-Cedillo; V. Baca-Muro; L. García-Conde; E. Lemus-Carmona

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PRS22 Cost-Effectiveness of Indacaterol

✍ A. Reyes-lopez; E.A. Lemus-carmona; E. Orozco 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PIN18 THE ESTABLISHMENT OF A COST-EFFECT

✍ VI Baca-Muro; IF Soria-Cedillo; J Jirash; K Olvera; T De la MoraChávez; F Garcia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PND2 Cost Offsets and Gains in Health Ef

✍ M. Ekman; R.E. White; P.E. Buck; N. Justo; P Lindgren 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCV86 Long-Term Cost-Effectiveness Analy

✍ A. Garcia-Castillo; M. De-los-Rios; A.C. Polanco; M.A. Ramirez; E. Nikolic; C. M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV56 Cost-Effectiveness of Dabigatran E

✍ V. Nasciben; M.J.D.O. Figueiredo; F.C.D.C. Darrieux; L.S.P. Piegas; S.C.O. Marti 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV48 Cost-Effectiveness of Dabigatran E

✍ V. Nasciben; M.J.D.O. Figueiredo; S.C.O. Martins; L.S.P. Piegas 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB